Profil
Dr. Martina Diekmann is a Chief Executive Officer at Mytide Therapeutics, Inc. and a President, Chief Executive Officer & Director at vivitite LLC.
She is on the Board of Directors at vivitite LLC.
Dr. Diekmann was previously employed as a Chief Executive Officer by New England Peptide, Inc. She received her doctorate degree from the University of Bonn.
Postes actifs de Martina Diekmann
| Sociétés | Poste | Début |
|---|---|---|
vivitite LLC
vivitite LLC Medical SpecialtiesHealth Technology Manufactures and distributes peptides, antibodies & bio-chemicals for research and development purposes | Directeur Général | 01/02/2020 |
Mytide Therapeutics, Inc.
Mytide Therapeutics, Inc. Packaged SoftwareTechnology Services Develops peptide synthesis technology | Directeur Général | 30/03/2023 |
Anciens postes connus de Martina Diekmann
| Sociétés | Poste | Fin |
|---|---|---|
New England Peptide, Inc.
New England Peptide, Inc. Chemicals: Major DiversifiedProcess Industries Designs and produces custom peptides and polyclonal antibodies | Directeur Général | - |
Formation de Martina Diekmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Bonn
University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Peptide, Inc.
New England Peptide, Inc. Chemicals: Major DiversifiedProcess Industries Designs and produces custom peptides and polyclonal antibodies | Process Industries |
Mytide Therapeutics, Inc.
Mytide Therapeutics, Inc. Packaged SoftwareTechnology Services Develops peptide synthesis technology | Technology Services |
vivitite LLC
vivitite LLC Medical SpecialtiesHealth Technology Manufactures and distributes peptides, antibodies & bio-chemicals for research and development purposes | Health Technology |
















